Team 

The Atonco team includes researchers, healthcare professionals, and medical industry experts who are highly experienced in their respective fields and very confident in the future of alpha-immunotherapy.

Jean-François CHATAL,
Chief Medical Officer >>

Sylvain FANIER,
CEO >>

Alexandra (GITEAU) PAILLARD, COO >>

Adrien REYMOND,
Business Develpment Director >>

Jacques BARBET, PhD , Chief Scientific Officer >>

Denis BILODEAU,
Clinical Research Developer >>

Clément MAYEUR,
Chief Financial Officer >>

Advisors

Jean-Pierre CABOCEL, EMBA, PhD Eng >>
Mario CAMPONE, MD, PhD >>
Jean-Marc LE DOUSSAL, PhD >>
Richard Valeix, MBA >>